10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The Human Immunodeficiency Virus (HIV) is a retrovirus with a complex life cycle involving the integration of viral genetic material into the host cell genome. HIV primarily targets CD4 T cells, macrophages, and dendritic cells, using the CD4 receptor and a co-receptor, typically CCR5 or CXCR4, for cellular entry. The reverse transcription process, mediated by the viral enzyme reverse transcriptase, results in the conversion of viral RNA into DNA, which is then integrated into the host cell DNA by the viral integrase. Antiretroviral drugs, classified into different classes such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs), target various stages of the viral life cycle. Despite the success of antiretroviral therapy (ART), the emergence of drug-resistant strains poses challenges to sustained treatment efficacy. Regular monitoring of viral load and drug resistance testing are essential for adapting treatment regimens and maintaining long-term viral suppression. Ongoing research into novel antiretroviral agents, including long-acting formulations and broadly neutralizing antibodies, aims to improve treatment options and address issues related to adherence. Efforts to develop an HIV vaccine continue, with the goal of inducing protective immune responses against the virus. Advances in gene therapy and genome editing technologies offer new avenues for exploring potential cures or sustained control of HIV infection. Understanding the dynamics of HIV transmission, the factors influencing reservoir establishment and persistence, and the interplay between the virus and the host immune response are active areas of investigation. Research endeavors, including clinical trials and collaborative international initiatives, contribute to the ongoing quest for a comprehensive understanding of HIV pathogenesis and the development of innovative strategies for prevention, treatment, and ultimately, a cure for HIV/AIDS.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States